SCHEMBL10107077

SCHEMBL10107077

COc1cc(Br)c(/C(C)=N/OCc2ccc(N=O)cc2)cc1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35
TUBA3E Q6PEY2 1/20 0.35
TUBA1A Q71U36 1/20 0.35
TUBA1C Q9BQE3 1/20 0.35
TUBB6 Q9BUF5 1/20 0.35
TUBB2B Q9BVA1 1/20 0.35
TUBB1 Q9H4B7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107307 0.89 TUBB4A (0.35) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL10106953 0.84 S1PR1 (0.39) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL660122 0.84 HTT (0.43) LMNASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL10107076 0.83 S1PR1 (0.43) LMNASMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL10107078 0.82 S1PR1 (0.41) SMN1; SMN2NPC1RAB9ATUBB4ATUBB
SCHEMBL10106954 0.82 S1PR1 (0.38) LMNASMN1; SMN2L3MBTL1TUBB4ATUBB
SCHEMBL10107079 0.82 HSP90AA1 (0.39) SMN1; SMN2NPC1RAB9ATUBB4ATUBB
SCHEMBL10107270 0.81 S1PR1 (0.38) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL10106946 0.81 S1PR1 (0.38) SMN1; SMN2L3MBTL1NPC1RAB9ATUBB4A
SCHEMBL10106955 0.81 CA12 (0.42) SMN1; SMN2NPC1RAB9ATUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 LMNA 2636/4885SMN1; SMN2 3060/4885L3MBTL1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.